RK
Ravi Kant Srivastava
About Ravi Kant Srivastava
Data last updated:
Ravi Kant Srivastava is a Director at Redicare Pharma Private Limited (since 2011). The company operates in Healthcare. Redicare Pharma Private Limited reported revenue of ₹3.43 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Redicare Pharma Private Limited U51909DL2011PTC225352 | Director | 22 Sep 2011 | 2011 | ₹3.43 Cr (FY 2025) | Active |
Board colleagues of Ravi Kant Srivastava
| Name | DIN | Company | Designation |
|---|---|---|---|
| Adesh Srivastava | 03607428 | Redicare Pharma Private Limited | Director |
| Sushil Srivastav | 03608541 | Redicare Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kant Srivastava
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kant Srivastava
Ravi Kant Srivastava currently holds 1 directorship: Redicare Pharma Private Limited (Director, since 22 Sep 2011, revenue ₹3.43 Cr (FY 2025)).
Ravi Kant Srivastava was first appointed on 22 Sep 2011 as Director at Redicare Pharma Private Limited.
The current boards of Ravi Kant Srivastava's companies include Adesh Srivastava (Redicare Pharma Private Limited), Sushil Srivastav (Redicare Pharma Private Limited).